APRICOT BIO MILESTONES
APRICOT BIO MILESTONES
Stay informed with the latest updates on our company and platform. We are committed to keeping our clients and partners up to date on our progress, innovations, and the continued growth of our project.
LATEST NEWS
12 January 2026
Nucleate Podcast
Boston-based Nucleate Podcast hosted Apricot BIO for a timely 2025 look-back, featuring Lucas Pelkmans, Professor of Systems Biology at the University of Zurich, and Dr. Andreas Wicki, single-cell omics expert at University Hospital Zurich.
4 September 2025
The 100 most innovative and promising Swiss startups are picked
Apricot BIO makes the 2025 list for TOP 100 Swiss Startups, ranking #89 overall and placing within the top 20 companies in our industry.
This recognition reflects a months-long evaluation process, conducted over the first eight months of the year by a jury over 90 experienced investors—far beyond a simple point-in-time vote.
30 June 2025
APx hits Boston for 2 weeks
We join nine other Swiss startups for a two-week immersion program in Boston, culminating in participation at BIO ‘25 and direct exposure to the U.S. biotech ecosystem and multiple opportunities to pitch to international investors.
6 May 2025
Apricot BIO participates in Venture Leaders Biotech 2025 Kickoff at Swiss Biotech Day ahead of Boston roadshow
An impactful 3 days in Basel - > 3'000 participants, ca. 45% joining from abroad, including 25 international delegations. The biggest and most international edition so far.
18 December 2022
First proof-of-concept partner signed
4 October 2022
Options agreement signed with University of Zurich (UZH) for exclusivity on 2 patent families
The basis of IP for Apricot BIO is agreed with University of Zurich and Unitectra, solidifying a key foundation for the company. We are grateful for the collaboration with UZH and look forward to many more milestones together.
6 September 2022
The birth of Apricot !
Registered and open for business
26 June 2022